Literature DB >> 22888853

The flexibility of P-glycoprotein for its poly-specific drug binding from molecular dynamics simulations.

Ming Liu1, Tingjun Hou, Zhiwei Feng, Youyong Li.   

Abstract

The multidrug efflux pump P-glycoprotein (P-gp) contributes to multidrug resistance in about half of human cancers. Recently, high resolution X-ray crystal structures of mouse P-gp (inward-facing) were reported, which significantly facilitates the understanding of the function of P-gp and the structure-based design of inhibitors for P-gp. Here we perform 20 ns molecular dynamics simulations of inward-facing P-gp with/without ligand in explicit lipid and water to investigate the flexibility of P-gp for its poly-specific drug binding. By analyzing the interactions between P-gp and QZ59-RRR or QZ59-SSS, we summarize the important residues and the flexibility of different parts of P-gp. Particularly, the flexibility of the side chains of aromatic residues (Phe and Tyr) allows them to form rotamers with different orientations in the binding pocket, which plays a critical role for the poly-specificity of the drug-binding cavity of P-gp. MD simulations reveal that trans-membrane (TM) TM12 and TM6 are flexible and contribute to the poly-specific drug binding, while TM4 and TM5 are rigid and stabilize the whole structure. We also construct outward-facing P-gp based on the MsbA structure and perform 20 ns MD simulations. The comparison between the MD results for outward-facing P-gp and those for inward-facing P-gp shows that the TM parts in outward-facing P-gp undergo significant conformational change to facilitate the export of small molecules.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22888853     DOI: 10.1080/07391102.2012.706079

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  6 in total

Review 1.  Blood-brain barrier structure and function and the challenges for CNS drug delivery.

Authors:  N Joan Abbott
Journal:  J Inherit Metab Dis       Date:  2013-04-23       Impact factor: 4.982

2.  Synthesis and In Vivo Imaging of N-(3-[11C]Methoxybenzyl)-2-(3-Methoxyphenyl)ethylaniline as a Potential Targeting Agent for P-glycoprotein.

Authors:  Debora Petroni; Antonietta Bartoli; Simona Rapposelli; Maria Digiacomo; Silvia Burchielli; Giulia Nesi; Annalina Lapucci; Silvia Pardini; Sabrina Fucci; Marco Macchia; Piero A Salvadori; Luca Menichetti
Journal:  Mol Imaging Biol       Date:  2016-12       Impact factor: 3.488

3.  Combined QSAR and molecule docking studies on predicting P-glycoprotein inhibitors.

Authors:  Wen Tan; Hu Mei; Li Chao; Tengfei Liu; Xianchao Pan; Mao Shu; Li Yang
Journal:  J Comput Aided Mol Des       Date:  2013-12-10       Impact factor: 3.686

4.  On the origin of large flexibility of P-glycoprotein in the inward-facing state.

Authors:  Po-Chao Wen; Brandy Verhalen; Stephan Wilkens; Hassane S Mchaourab; Emad Tajkhorshid
Journal:  J Biol Chem       Date:  2013-05-08       Impact factor: 5.157

5.  Molecular docking simulations provide insights in the substrate binding sites and possible substrates of the ABCC6 transporter.

Authors:  Mohammad Jakir Hosen; Abdullah Zubaer; Simrika Thapa; Bijendra Khadka; Anne De Paepe; Olivier M Vanakker
Journal:  PLoS One       Date:  2014-07-25       Impact factor: 3.240

6.  Pore-exposed tyrosine residues of P-glycoprotein are important hydrogen-bonding partners for drugs.

Authors:  Yaprak Dönmez Cakil; Narakorn Khunweeraphong; Zahida Parveen; Diethart Schmid; Matthias Artaker; Gerhard F Ecker; Harald H Sitte; Oliver Pusch; Thomas Stockner; Peter Chiba
Journal:  Mol Pharmacol       Date:  2013-12-23       Impact factor: 4.436

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.